MedTrace Logo

Gabapentin Treatment of Cannabis Dependence

NCT00395044 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-02-10

Study results available
· View outcomes & findings →

Summary

This is a study to evaluate the efficacy of the medication gabapentin in treating persons with cannabis dependence.

Conditions

  • Cannabis Dependence

Interventions

DRUG

Placebo

Placebo

DRUG

Gabapentin

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • The Scripps Research Institute

    lead OTHER

Principal Investigators

  • Barbara J. Mason, Ph.D. · The Scripps Research Institute- Pearson Center for Alcoholism and Addiction Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2008-07-31
Completion
2008-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00395044 on ClinicalTrials.gov